257 related articles for article (PubMed ID: 17482943)
1. Initial trial of timed voiding is warranted for all children with daytime incontinence.
Allen HA; Austin JC; Boyt MA; Hawtrey CE; Cooper CS
Urology; 2007 May; 69(5):962-5. PubMed ID: 17482943
[TBL] [Abstract][Full Text] [Related]
2. Frequency of wetting is predictive of response to anticholinergic treatment in children with overactive bladder.
Van Arendonk KJ; Austin JC; Boyt MA; Cooper CS
Urology; 2006 May; 67(5):1049-53; discussion 1053-4. PubMed ID: 16698366
[TBL] [Abstract][Full Text] [Related]
3. The effect of biofeedback treatment on voiding and urodynamic parameters in children with voiding dysfunction.
Yagci S; Kibar Y; Akay O; Kilic S; Erdemir F; Gok F; Dayanc M
J Urol; 2005 Nov; 174(5):1994-7; discussion 1997-8. PubMed ID: 16217376
[TBL] [Abstract][Full Text] [Related]
4. Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?
Yucel S; Akkaya E; Guntekin E; Kukul E; Danisman A; Akman S; Baykara M
Urology; 2005 Feb; 65(2):369-73. PubMed ID: 15708055
[TBL] [Abstract][Full Text] [Related]
5. Management of abnormal postvoid residual urine in children with dysfunctional voiding.
Kibar Y; Piskin M; Irkilata HC; Aydur E; Gok F; Dayanc M
Urology; 2010 Jun; 75(6):1472-5. PubMed ID: 19896172
[TBL] [Abstract][Full Text] [Related]
6. The impact of daytime diuresis on voiding frequency and incontinence classification in children.
Mahler B; Hagstroem S; Rittig N; Mikkelsen MM; Rittig S; Djurhuus JC
J Urol; 2008 Jun; 179(6):2384-8. PubMed ID: 18433779
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of transcutaneous electrical nerve stimulation in children with overactive bladder refractory to pharmacotherapy.
Malm-Buatsi E; Nepple KG; Boyt MA; Austin JC; Cooper CS
Urology; 2007 Nov; 70(5):980-3. PubMed ID: 17919697
[TBL] [Abstract][Full Text] [Related]
8. Biofeedback training for lower urinary tract symptoms: factors affecting efficacy.
Drzewiecki BA; Kelly PR; Marinaccio B; Borer JG; Estrada CR; Lee RS; Bauer SB
J Urol; 2009 Oct; 182(4 Suppl):2050-5. PubMed ID: 19695584
[TBL] [Abstract][Full Text] [Related]
9. Objective versus subjective outcome measures of biofeedback: what really matters?
Berry A; Rudick K; Richter M; Zderic S
J Pediatr Urol; 2014 Aug; 10(4):620-6. PubMed ID: 25070936
[TBL] [Abstract][Full Text] [Related]
10. Voiding habits and wetting in a population of 4,332 Belgian schoolchildren aged between 10 and 14 years.
Bakker E; van Sprundel M; van der Auwera JC; van Gool JD; Wyndaele JJ
Scand J Urol Nephrol; 2002; 36(5):354-62. PubMed ID: 12487740
[TBL] [Abstract][Full Text] [Related]
11. Results of biofeedback treatment on reflux resolution rates in children with dysfunctional voiding and vesicoureteral reflux.
Kibar Y; Ors O; Demir E; Kalman S; Sakallioglu O; Dayanc M
Urology; 2007 Sep; 70(3):563-6; discussion 566-7. PubMed ID: 17905115
[TBL] [Abstract][Full Text] [Related]
12. Primer: diagnosis and management of uncomplicated daytime wetting in children.
Vemulakonda VM; Jones EA
Nat Clin Pract Urol; 2006 Oct; 3(10):551-9. PubMed ID: 17031380
[TBL] [Abstract][Full Text] [Related]
13. Improved efficacy of extended release oxybutynin in children with persistent daytime urinary incontinence converted from regular oxybutynin.
Van Arendonk KJ; Knudson MJ; Austin JC; Cooper CS
Urology; 2006 Oct; 68(4):862-5. PubMed ID: 17070368
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcome of day-time urinary incontinence in children.
Hagstroem S; Rittig N; Kamperis K; Mikkelsen MM; Rittig S; Djurhuus JC
Scand J Urol Nephrol; 2008; 42(6):528-33. PubMed ID: 18609267
[TBL] [Abstract][Full Text] [Related]
15. Effect of tamsulosin on systemic blood pressure and nonneurogenic dysfunctional voiding in children.
Vanderbrink BA; Gitlin J; Toro S; Palmer LS
J Urol; 2009 Feb; 181(2):817-22; discussion 822. PubMed ID: 19110267
[TBL] [Abstract][Full Text] [Related]
16. The relevance of urodynamic studies for Urge syndrome and dysfunctional voiding: a multicenter controlled trial in children.
Bael A; Lax H; de Jong TP; Hoebeke P; Nijman RJ; Sixt R; Verhulst J; Hirche H; van Gool JD;
J Urol; 2008 Oct; 180(4):1486-93; discussion 1494-5. PubMed ID: 18710726
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type A in combination with standard urotherapy for children with dysfunctional voiding.
Petronijevic V; Lazovic M; Vlajkovic M; Slavkovic A; Golubovic E; Miljkovic P
J Urol; 2007 Dec; 178(6):2599-602; discussion 2602-3. PubMed ID: 17945299
[TBL] [Abstract][Full Text] [Related]
18. Clinical differences in daytime wetting subtypes: urge incontinence and postponed voiding.
Kuhn S; Natale N; Siemer S; Stoeckle M; von Gontard A
J Urol; 2009 Oct; 182(4 Suppl):1967-72. PubMed ID: 19695641
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness of transcutaneous electrical neural stimulation therapy in patients with urinary incontinence resistant to initial medical treatment or biofeedback.
Tugtepe H; Thomas DT; Ergun R; Kalyoncu A; Kaynak A; Kastarli C; Dagli TE
J Pediatr Urol; 2015 Jun; 11(3):137.e1-5. PubMed ID: 25824876
[TBL] [Abstract][Full Text] [Related]
20. Daytime urinary incontinence among kindergarten children in Aden Governorate, 2003.
Yousef KA; Basaleem HO; Al-Sakkaf KA
Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1092-9. PubMed ID: 21060179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
